glp-1 medications ozempic 1 in 8 adults in the US has taken or another drug, KFF survey finds How to Find a Health

Description

Additionally, the impact of emerging technologies such as digital health tools and telemedicine on patient outcomes and care delivery needs further investigation to enhance care accessibility and cost-effectiveness in diverse settings

The second compared GLP-1 receptor agonist users with patients receiving insulin or metformin among those with type 2 diabetes

Research Insight: Clinical trials have consistently shown that GLP-1 receptor agonists lead to significant delays in gastric emptying, contributing directly to reduced food intake and weight loss

Last reviewed: July 9, 2026 Last updated: July 9, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations

The rising prevalence of type 2 diabetes and obesity, innovations such as oral formulations and long-acting drugs, increased patient awareness, and regulatory approvals drive the GLP-1 Analogues market